VIKING THERAPEUTICS INC (VKTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$34.87+2.62%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VKTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 509.3 | 345.0 | 101.6 | 63.8 | 54.2 | 45.0 | 31.9 | 23.6 | 19.0 | 13.7 | 9.0 | 7.0 |
| Operating Income | (560.0) | (393.3) | (150.9) | (100.8) | (70.4) | (55.7) | (42.7) | (32.7) | (26.2) | (19.1) | (13.8) | (12.0) |
| Earnings from Continuing Operations | ||||||||||||
| EBT, Incl. Unusual Items | — | (359.6) | — | (85.9) | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | ||||||||||||
| Net Income | (534.8) | (359.6) | (110.0) | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) | (23.4) |
| Per Share | ||||||||||||
| Basic EPS | (4.60) | (3.19) | (1.01) | (0.91) | (0.90) | (0.71) | — | — | — | — | — | — |
| Diluted EPS | (4.60) | (3.19) | (1.01) | (0.91) | (0.90) | (0.71) | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 116.3 | 112.7 | 109.0 | 94.3 | 76.8 | 77.2 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 116.3 | 112.7 | 109.0 | 94.3 | 76.8 | 77.2 | — | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBIT | (560.0) | (393.3) | (150.9) | (100.8) | (70.4) | (55.7) | (42.7) | (32.7) | (26.2) | (19.1) | (13.8) | (12.0) |
| Effective Tax Rate | — | — | — | -0.0% | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.